Tenovi

Tenovi operates as a B2B data aggregation and automation platform within the healthcare technology sector, specifically focusing on remote patient monitoring (RPM) and remote therapeutic monitoring (RTM). Founded in 2020 by Dr. Nizan Friedman, a biomedical engineer and second-time medtech founder, the company is headquartered in Portsmouth, NH, with an additional office on the East Coast. The company has secured $4.68 million in funding over two rounds, including a $4.2 million Series A in August 2023, to fuel its expansion and R&D efforts.

The core of Tenovi's business is to serve as a technology partner for other RPM companies, not to sell directly to healthcare providers. It provides the essential infrastructure for these companies to build and scale their remote care programs. The business model is centered on providing a comprehensive suite of hardware, software, and logistical services. This includes a single API that grants access to data from over 40 integrated medical devices, fulfillment automation that handles procurement and direct-to-patient shipping, and US-based technical support.

Tenovi's product ecosystem is designed for ease of use, particularly for patient populations that may not be tech-savvy, such as older adults. The central component is the proprietary Tenovi Cellular Gateway, a plug-and-play device that requires no Wi-Fi or smartphone apps. It automatically connects to cellular networks to transmit data from various FDA-cleared, Bluetooth-enabled medical devices. The gateway features a simple LED light system to confirm data transmission, enhancing patient adherence. The platform integrates with a wide array of devices, including blood pressure monitors, glucose meters, scales, pulse oximeters, and smart pillboxes. This allows Tenovi's partners to offer monitoring for numerous chronic conditions like hypertension, diabetes, and heart failure, as well as for maternity care.

By acting as the connective tissue between medical device manufacturers and RPM service providers, Tenovi enables its clients to access new markets and patient populations without the overhead of managing inventory, logistics, and multiple device integrations. The company has established partnerships with over 180 RPM firms and has deployed more than 100,000 devices. Its system is designed for scalability, allowing partners to manage programs from a few patients to over a million through a single, unified platform.

Keywords: remote patient monitoring, RPM platform, remote therapeutic monitoring, RTM, healthcare IoT, cellular gateway, medical device integration, health data aggregation, B2B healthtech, connected health devices, chronic disease management, telehealth infrastructure, FDA-cleared medical devices, patient monitoring hardware, clinical data transmission, digital health solutions, Nizan Friedman, API integration, healthcare logistics, patient adherence technology